INTERNATIONAL PATENT: PRINCIPIA BIOPHARMA INC. FILES APPLICATION FOR "FORMULATIONS OF 2-[(3R)-2-[4-AMINO-3-(2-FLUORO-4-PHENOXY- PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-L-YL]PIPERIDINE-L-CARBONYL]-4- METHYL-4[4-(OXETAN-3-YL)PIPERAZIN-L-YL]-PENT-2-ENENITRILE"

GENEVA, Oct. 1 -- PRINCIPIA BIOPHARMA INC. (55 Corporate DriveBridgewater, New Jersey 08807) filed a patent application (PCT/US2025/020419) for "FORMULATIONS OF 2-[(3R)-2-[4-AMINO-3-(2-FLUORO-4-PHENOXY- PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-L-YL]PIPERIDINE-L-CARBONYL]-4- METHYL-4[4-(OXETAN-3-YL)PIPERAZIN-L-YL]-PENT-2-ENENITRILE" on Mar 18, 2025. With publication no. WO/2025/199134, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DA CRUZ, Henri (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris), JEANJEAN, Aud...